Not Yet RecruitingPhase 2Phase 3ACTRN12606000024549

Randomised placebo controlled trial on the safety and efficacy of Biolane in osteoarthritis

Randomised placebo controlled trial on the safety and efficacy of Biolane in osteoarthritis of the knees and/or hips


Sponsor

Healtheries of New Zealand Ltd

Enrollment

100 participants

Start Date

Jan 30, 2006

Study Type

Interventional

Conditions


Eligibility

Sex: Both males and femalesMin Age: 18 YearssMax Age: 75 Yearss

Inclusion Criteria1

  • Total WOMAC score of >30 at baseline-x-ray and clinical evidence of osteoarthritis of the knees and/or hips.

Exclusion Criteria1

  • Gout, rheumatoid arthritis or other inflammatory joint condition-Allergy to seafood or gelatine-Use of monoamine oxidase inhibitors-Use of corticosteroids within 4 weeks prior to baseline and throughout the study-Use of aspirin or anti-inflammatory agents 3 weeks prior to baseline and for the duration of the study-Use of complementary anti-arthritic medicines 6 weeks prior to baseline and for the duration of the study-Liver function tests greater then 3 times the upper limit of normal at baseline.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

Biolane for a period of 18 weeks

Biolane for a period of 18 weeks


Locations(1)

Australia

View Full Details on ANZCTR

For the most up-to-date information, visit the official listing.

Visit

ACTRN12606000024549